Overview

This protocol is designed to assess immunotherapeutic redirected T-cell (CAR T-cell) cytotoxicity against 3D structured cancerous cells (spheroids) in real time. The method combines advanced imaging technology with a sensitive immunological assay to evaluate immune cell effectiveness.

Key Study Components

Area of Science

Immunotherapy
Cancer Biology
Cellular Assays

Background

Immunotherapy is a promising approach in cancer treatment.
Understanding T-cell cytotoxicity is crucial for developing effective therapies.
3D tumor models better mimic the in vivo environment compared to traditional 2D cultures.
Real-time assessment allows for dynamic monitoring of cell interactions.

Purpose of Study

To evaluate the cytotoxic effects of CAR T-cells on 3D tumor spheroids.
To provide a straightforward method for assessing immune responses.
To enhance understanding of T-cell behavior in a 3D context.

Methods Used

Washing colorectal cancer cell lines with PBS.
Detaching cells using trypsin and confirming under a microscope.
Neutralizing trypsin with complete medium and centrifuging cells.
Resuspending cells for counting and seeding into a 96-well plate.

Main Results

Successful detachment and resuspension of cancer cells.
Real-time imaging of T-cell interactions with tumor spheroids.
Assessment of cytotoxicity levels over time.
Insights into the effectiveness of CAR T-cell therapy.

Conclusions

The method provides a reliable way to study T-cell cytotoxicity.
Real-time imaging enhances the understanding of immune responses.
This approach can aid in the development of more effective immunotherapies.

Frequently Asked Questions

What is CAR T-cell therapy?

CAR T-cell therapy is a form of immunotherapy that modifies a patient's T-cells to better recognize and attack cancer cells.

Why use 3D tumor models?

3D tumor models more accurately replicate the tumor microenvironment, providing better insights into cell behavior and treatment responses.

How does the imaging technology work?

The imaging technology captures real-time interactions between T-cells and tumor spheroids, allowing for dynamic analysis of cytotoxicity.

What are the advantages of this method?

The method is straightforward, combines advanced imaging with immunological assays, and allows for real-time monitoring of immune responses.

Can this method be applied to other cancer types?

Yes, the protocol can be adapted for various cancer cell lines to assess T-cell cytotoxicity across different tumor types.

Institution - Oslo University Hospital-Radiumhospitalet

Articles Published in JoVE